H.U. Group Holdings Inc
TSE:4544

Watchlist Manager
H.U. Group Holdings Inc Logo
H.U. Group Holdings Inc
TSE:4544
Watchlist
Price: 3 419 JPY 0.29% Market Closed
Market Cap: 196.5B JPY

H.U. Group Holdings Inc
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

H.U. Group Holdings Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
H.U. Group Holdings Inc
TSE:4544
Net Income (Common)
ÂĄ1.4B
CAGR 3-Years
-63%
CAGR 5-Years
N/A
CAGR 10-Years
-22%
E
Elan Corp
TSE:6099
Net Income (Common)
ÂĄ2.4B
CAGR 3-Years
4%
CAGR 5-Years
16%
CAGR 10-Years
22%
Solasto Corp
TSE:6197
Net Income (Common)
ÂĄ4.3B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
N/A
BML Inc
TSE:4694
Net Income (Common)
ÂĄ6.4B
CAGR 3-Years
-39%
CAGR 5-Years
8%
CAGR 10-Years
6%
V
Value HR Co Ltd
TSE:6078
Net Income (Common)
ÂĄ617.4m
CAGR 3-Years
-9%
CAGR 5-Years
3%
CAGR 10-Years
18%
France Bed Holdings Co Ltd
TSE:7840
Net Income (Common)
ÂĄ2.8B
CAGR 3-Years
6%
CAGR 5-Years
12%
CAGR 10-Years
10%
No Stocks Found

H.U. Group Holdings Inc
Glance View

Market Cap
194.3B JPY
Industry
Health Care

H.U.Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. The company is headquartered in Shinjuku, Tokyo-To and currently employs 5,897 full-time employees. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The firm operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.

Intrinsic Value
5 180.56 JPY
Undervaluation 34%
Intrinsic Value
Price

See Also

What is H.U. Group Holdings Inc's Net Income (Common)?
Net Income (Common)
1.4B JPY

Based on the financial report for Jun 30, 2025, H.U. Group Holdings Inc's Net Income (Common) amounts to 1.4B JPY.

What is H.U. Group Holdings Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-22%

The average annual Net Income (Common) growth rates for H.U. Group Holdings Inc have been -63% over the past three years , and -22% over the past ten years .

Back to Top